𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development

✍ Scribed by D Seurin; C Lassarre; G Bienvenu; S Babajko

Book ID
117659044
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
200 KB
Volume
38
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Overexpression of insulin-like growth fa
Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo
✍ Marisa A. Gallicchio; Malea Kneen; Cathrine Hall; Andrew M. Scott; Leon A. Bach πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 115 KB

Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood. Rhabdomyosarcoma cell lines overexpress insulin-like growth factor-II (IGF-II), an autocrine growth factor that is inhibited by insulin-like growth factor binding protein-6 (IGFBP-6). IGFBP-6 is associated with myoblast quiescence

Expression of insulin-like growth factor
Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation
✍ Jung H. Y. Park; Mark R. Corkins; Jon A. Vanderhoof; Nia M. Caruso; Marjorie J. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 790 KB

differentiation is linked to growth of Caco-2 cells, with markers of functional differentiation increasing only after the cells stop proliferating (Pinto e t al., 1983). Given these limitations, Caco-2 cells appear to represent the most relevant in vitro model currently available for study of prolif

Insulin-like growth-factor-binding prote
Insulin-like growth-factor-binding protein gene expression and protein production by human tumour cell lines
✍ Julie G. Reeve; Lemuel B. Kirby; Ad Brinkman; Stephanie A. Hughes; Jurg Schwande πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 828 KB

The secretion of insulin-like growth-factor-binding proteins (IGFBPs) and expression of the genes encoding IGFBP-I, IGFBP-2 and IGFBP-3 have been studied in a panel of cell lines derived from breast carcinomas, Wilms' tumour, neuroblastoma, retinoblastoma, colon carcinoma, liver adenocarcinoma, Burk